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Notch  signaling  is  an  evolutionarily  conserved  pathway,  which  is  fundamental  for  neuronal  develop-
ment  and  speciﬁcation.  In the  last  decade,  increasing  evidence  has  pointed  out  an important  role  of this
pathway  beyond  embryonic  development,  indicating  that  Notch  also  displays  a critical  function  in the
mature  brain  of vertebrates  and  invertebrates.  This  pathway  appears  to  be  involved  in neural  progenitor
regulation,  neuronal  connectivity,  synaptic  plasticity  and  learning/memory.  In  addition,  Notch  appears
to  be  aberrantly  regulated  in neurodegenerative  diseases,  including  Alzheimer’s  disease  and  ischemic
injury.  The  molecular  mechanisms  by  which  Notch  displays  these  functions  in  the  mature  brain  are  not
fully  understood,  but  are  currently  the  subject  of  intense  research.  In  this review,  we will discuss  old  and
novel  Notch  targets  and  molecular  mediators  that  contribute  to Notch  function  in the  mature  brain  and
will  summarize  recent  ﬁndings  that  explore  the  two  facets  of Notch  signaling  in brain  physiology  and
pathology.
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1. Introduction
In the name of nature’s conservationist character, the mature
brain employs an array of developmental pathways to  regulate
higher cognitive functions (Herz and Chen, 2006; Meffert and
Baltimore, 2005; Speese and Budnik, 2007). Notch signaling is  one
of the best examples. This pathway is  expressed throughout the
lifespan of an animal from development (de la Pompa et al., 1997)
to adulthood (Berezovska et al., 1998), and crosstalks with other
signaling cascades in a context dependent manner.
Based on its temporally ubiquitous function, alteration to
this cascade result from growth arrest (Swiatek et al., 1994) to
brain diseases such as cerebral autosomal dominant arteriopa-
thy with subcortical infarcts and leukoencephalopathy (CADASIL)
(Arboleda-Velasquez et al., 2011), Alzheimer’s disease (AD)
(Berezovska et al., 1998; Steiner et al., 1999), Down syndrome
(Fischer et al., 2005), stroke (Arumugam et al., 2006) and brain
tumors (Dang et al., 2006; Pierfelice et al., 2011). The fact that Notch
has such pleiotropic effects in  the brain and other organs has posed
a critical question in  unraveling its role in  the different cell types.
Studies taking advantage of cre/loxP mouse genetics have been able
to  overcome the developmental requirement of Notch in  embry-
onic growth and focus on the speciﬁc role of Notch in the mature
brain and in a time-dependent manner (Table 1). In  addition, Notch
reporter mouse lines have provided spatial and temporal resolution
of Notch signaling in  the embryonic and mature brain, overcoming
the paucity of good antibodies for Notch targets (Table 1). Taken
together, mouse genetics tools have greatly improved our knowl-
edge on the role of this signaling pathway in  the postnatal brain.
Following these strong advancements, remarkable work is ongo-
ing to untangle the complexity of the Notch cascade in the mature
brain. For a long time, it was thought that Notch activity in  neurons
was restricted to its transcriptional potential (Costa et al., 2003;
Sestan et al., 1999). However, there are now numerous reports
indicating that Notch crosstalks with other conserved pathways
to complement its array of functions both in physiological (Alberi
et al., 2011; Giniger, 1998; Hashimoto-Torii et al., 2008; Lugert et al.,
2010; Wang et al., 2004) and pathological conditions (Arumugam
et al., 2006, 2011; Leal et al., 2012; Yang et al., 2004) (Fig.  1).
This  review aims to summarize the most recent studies that have
revealed some of the molecular mechanisms underlying Notch sig-
naling in the mature mammalian brain. We  will try to explain some
of the unsolved mechanisms by looking into other biological set-
tings, such as cancer and Drosophila biology, to  ﬁnd inspiration and
support for future investigations.
Advances in  understanding this cascade are  highly relevant, not
only for basic science, but offers a concrete potential for developing
therapeutic strategies to counteract alterations in  Notch signaling.
2. The Notch pathway: an overview
2.1. The Notch pathway and its hallmarks
The Notch pathway is highly conserved in metazoans (Gazave
et al., 2009). It occurs early on in  development, when cell-to-
cell contact determines morphogenesis (Artavanis-Tsakonas et al.,
1999). Notch receptors are membrane-tethered proteins with
characteristic epidermal growth factor (EGF)-like repeats on the
extracellular portion (Rebay et al., 1991) and an intracellular
transcriptional active site (Fortini and Artavanis-Tsakonas, 1994;
Schroeter et al., 1998). In mammals, native Notch is cleaved at
the endoplasmic reticulum (ER) by furin (S1 cleavage) that splits
the extracellular and transmembrane portion into a  mature recep-
tor dimer held by a  calcium (Ca2+) bond. In vertebrates, there are
four Notch receptor paralogues: Notch1, 2, 3 and 4. The receptors
are activated by speciﬁc ligands of the Jagged and Delta serrate
member families, which are  expressed on the membrane of adja-
cent cells and contain a  DSL  (Delta-serrate-lag-2) motif, essential
for binding to  Notch (Lindsell et al., 1996; Nye and Kopan, 1995).
When the juxtaposed ligand binds to  Notch, dimerization of the
receptor occurs (Mumm  et al., 2000). The extracellular portion is
endocytosed with the ligand in  the adjacent signaling cell and the
membrane bound portion of the receptor undergoes sequential
processing (Parks et al., 2000) (Fig. 2). The second cleavage (S2)
Table 1
.4
Mouse model Phenotype Paper
Notch1 LOF models
Notch1+/−  Learning and memory deﬁcit Costa et al. (2003)
Notch1as Synaptic plasticity deﬁcit Wang et al. (2004)
RBPJK+/− Learning and memory deﬁcit Costa et al. (2003)
Notch1f/f x T29-1CamK::cre Synaptic plasticity and learning deﬁcit Alberi et al. (2011)
RBPJKf/f x TgCamK::cre Odor discrimination deﬁcit (only females) Sato et al. (2012)
Notch1 f/f x CamKII::cre (CaMcre) No phenotype detected Zheng et  al. (2012)
Notch2 f/f x CamKII::cre (CaMcre) No phenotype detected Zheng et  al. (2012)
RBPJKf/f x Nes::cre ERT2 Neurogenesis defect in SVZ Basak et al. (2012); Imayoshi et al. (2010)
RBPJKf/f x GLAST::cre ERT2 Neurogenesis defect in SGZ Lugert et al. (2010)
Notch1f/f x Nes::cre ERT2 Depletion of active NSC in SVZ Lugert et al. (2012)
Notch1 GOF models
Thy::  LSLNICD x G35-3::cre Synaptic and visual plasticity deﬁcit Dahlhaus et  al. (2008)
Notch reporter mice
RBPJKRE::EGFP Notch/RBPJK signaling reporter Mizutani et al. (2007)
RBPJKRE::nLacZ Notch/RBPJK signaling reporter Souilhol et al. (2006)
pHes1:;dEGFP pHes5::dEGFP Notch/RBPJK signaling reporters Ohtsuka et al. (2006)
Hes5:: EGFP Notch/RBPJK signaling reporter Basak and Taylor (2007)
NIP-cre Notch proteolysis reporter Vooijs et al. (2007)
Hes5-nlsLacZ Notch/RBPJK signaling reporter Imayoshi et  al. (2010)
Hes1::EmGFPSAT Notch/RBPJK signaling reporter Fre et al. (2011)
Notch-GAL4VP16  Notch activation dosage reporter Smith et al. (2012)
Abbreviations: LOF, loss of function; GOF, gain of function; ﬂ,  ﬂox allele; cre, cre recombinase; CamKII, calcium calmodulin kinase II; ERT2 , estrogen receptor tamoxifen inducible
2;  Nes, Nestin; GLAST, glutamate aspartate transporter; Thy, neuron speciﬁc promoter; LSL, Lox-Stop-Lox; EGFP, enhanced green ﬂuorescent protein; dEGFP, destabilized
enhanced green ﬂuorescent protein; NIP, Notch intramembrane proteolysis; LacZ, -galactosidase; EmGFP, emerald green ﬂuorescent protein; GAL4, galactosidase activator
protein; VP16, herpes simplex virus (HSV)-encoded transcriptional activator.
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Fig. 1. Brain function and dysfunction through Notch signaling. Simplistic representation of the Notch/RBPJK signaling cascade, which is  involved (arrows) in physiological
brain functions (“good times”) or pathological conditions (“bad times”) in the mature brain. A sketch of a  mouse brain is  represented. Box indicating Notch crosstalks, which
are  involved in the two  scenarios.
is then operated by disintegrin and metalloproteinases (ADAM-
17 and ADAM-10), while the transmembrane domain is available
for -secretase processing. Presenilins (PS1 and PS2) of the -
secretase complex generate the Notch intracellular domain (NICD)
(S3-cleavage) (Mumm  et al., 2000), and a  transmembrane petide
(N) (S4 cleavage) (Okochi et al., 2002) (Fig. 2).
In  the canonical signaling, once NICD is  generated, it is translo-
cated to the nucleus through the binding of importins- to  its
nuclear localization sequence (NLS) domain (Huenniger et al.,
2010). Nuclear NICD associates with the transcriptional repressor
RBPJK (recombination signal binding protein for immunoglobu-
lin kappa J, also called CBF1, suppressor of hairless, lag-1), the
co-activator protein MAML-1 (mastermind-like-1), and p300/CBP
(CREB-binding protein), which possess histone acetyltransferase
(HAT) activity and allows dissociation of the repressor complex
formed by Skip (Ski-interacting protein), SMRT (nuclear receptor
corepressor 2) and histone deacetylase (HDAC). This displacement
converts RBPJK from a  repressor to an activator (Kopan and Ilagan,
2009) (Fig. 2). The Notch–RBPJK complex initiate transcription of
target genes, Hes (Hairy and Enhancer of Split in  ﬂies), Herp (Hes-
related proteins) (Iso  et al., 2003), Sox2 (Ehm et al., 2010) and Pax6
(Kumar and Moses, 2001), that are involved in  cell proliferation
and stem cell maintenance. Notch/RBPJK signaling also controls
expression of cell cycle regulators such as cyclinD1 (Ronchini and
Capobianco, 2001) and cell growth factors as c-Myc (Palomero et al.,
2007). In addition, a  recent genome-wide analysis of NICD/RBPJK
targets has identiﬁed, in embryonic forebrain progenitors, signal-
ing components of the Wnt, Shh, Hippo and ionotropic glutamate
receptor pathways as direct canonical targets (Li et al., 2012). Using
high throughput technologies, this study has indicated, for the ﬁrst
time, a wide array of genes that are under Notch regulation. It is
expected that Notch/RBPJK signaling, in development as well as in
mature neurons, regulates many of these genes.
On the other hand, it appears that Notch also displays non-
transcriptional activity that is essential for the crosstalk with
other signaling components, including Rho-GTPase (Giniger, 1998),
which mediates morphogenesis in  differentiating neurons.
In the following sections we will discuss critical mech-
anisms that regulate Notch expression, transcriptional and
non-transcriptional activity.
2.2. The Notch receptors in the mature brain
Notch1 is  expressed in pyramidal neurons of the cortex
(Redmond et al., 2000; Sestan et al., 1999; Stump et al., 2002) and
hippocampus (Stump et al., 2002). Speciﬁcally in the hippocampus,
Notch expression is  induced by sensory experience and can behave
as a novel “plasticity molecule”: it is expressed postsynaptically and
regulates spine morphology, synaptic plasticity and memory pro-
cessing (Alberi et al., 2011; Costa et al., 2003; Wang et al., 2004). On
the other hand, Notch1 is strongly induced following brain injury
(Alberi et al., 2010; Arumugam et al., 2006) and may contribute to
cell  death. Notch2 expression pattern is  similar to  Notch1, how-
ever, it is expressed at lower levels in cortical and hippocampal
neurons as compared to Notch1 (Stump et al., 2002). Notch2 is
also critically upregulated upon injury and appears to contribute
to brain damage (Alberi et al., 2010; Ferrari Toninelli et  al., 2003).
Notch3 is  mostly expressed in  astroglial progenitors (Tanigaki et  al.,
2001), choroid plexus (Dang et al., 2006) and vasculature (Joutel
et al., 2000), whereas Notch4 has, so far, not been detected. On
the whole, it appears that Notch expression is dynamically regu-
lated and that alterations in pathway activity can interfere with
physiological functions and affect cellular homeostasis.
2.3. The Delta-serrate-lag-2 ligands and others
The Notch ligands of the Jagged and Delta serrate member fam-
ilies are expressed on the membrane of adjacent signaling cells
and contain a  DSL-motif that is  essential for binding to Notch
(Lindsell et al., 1996; Nye and Kopan, 1995). In the mature brain,
the ligands Jagged1 and Jagged2 are prevalent in  the forebrain,
whereas Delta-like1 and Delta-like3 are  expressed at low lev-
els in  the cortex and the cerebellum, respectively (Stump et  al.,
2002). Our previous study conﬁrmed that, in mature hippocampal
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Fig. 2. Working model for Notch1 signaling in physiological conditions. Notch1 is expressed postsynaptically in the receiving cell whereas the  ligand is expressed presynap-
tically in the signaling cell. Contact of Notch1 and Jagged1 ectodomains leads to  dissociation of the extracellular portion of Notch and internalization in the signaling cell.
Notch1 and Jag1 may  be found at the same membrane side, in “cis” conﬁguration, in which Notch activation is inhibited. In addition, the ligand may  get processed/shedded
at the presynaptic site and internalized with Notch in the receiving cell. Notch1 expression is  regulated by  furin cleavage (S1). Furin activity is under negative regulation
of a novel protein “Botch” Notch1. Expression of Notch from pre-existing mRNA is  activity dependent. Following activity Notch is  rapidly recycled (Rab11) possibly from
extrasynaptic to synaptic sites. Notch and APP are both expressed postsynaptically and following synaptic stimulation through NMDA receptors are cleaved at the membrane
by  proteases, ADAM (S2), Presenilin1 and 2  (PS1/2) (S3) are represented. NICD and AICD physically interact and reciprocally inhibit each other through Numb, which sends
them to degradation. Notch interacts also with Reelin receptors (ApoER2 is  represented) and they crosstalk through Dab/Abl signaling cascade. The trafﬁcking of Arc/Arg3.1
facilitates NICD generation, through S3 cleavage, probably at  the level of the endosome. NICD is  internalized in the nucleus, displaces SMRT and binds to RBPJK and MAML
to  form a transcriptional complex that induces expression of speciﬁc target genes of the Hes and Herp gene family, Sox2 and other known and yet unknown genes. NICD
activity is negatively regulated by CDK8, which phosphorylates NICD and sends to degradation through Fbw7. The gray separation indicates the long-range distance between
a  dendritic synapse and the cell soma/nucleus.
neurons, Jagged1 is  prevalent and is expressed at presynaptic sites,
whereas levels of Delta-like1 are  negligible (Alberi et al., 2011).
This also appears to be  the case in  the postnatal subventricular
zone where Jagged1 regulates proliferation of Notch-expressing
neural stem cells (NSC) (Nyfeler et al., 2005). Interestingly, we
have observed that, in mature neurons, the expression of Jagged1
increases in response to synaptic stimulation whereas Delta-like1
remains unchanged (Alberi et al., 2011). On the other hand, in
Drosophila, Delta1 seems to  be the relevant Notch ligand from
development to the mature brain (Lieber et al., 2011; Muskavitch,
1994).  It is  not clear why ligand functions and topology are not
conserved, but the separation of Delta and Jagged expression in  dif-
ferent metazoan species has recently been reported (Gazave et al.,
2009).
Additionally, Notch is induced by atypical ligands, that lack the
DSL domain, such as Delta/Notch-like EGF related receptor (DNER)
(Eiraku et al., 2002) and F3/contactin family members: MB3 and
Contactin1 (D‘Souza et al., 2008). Interestingly, these ligands are
expressed in  dendrites, and axons (Kurisu et al., 2010; Pierre et  al.,
2001).
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On the whole, the presence of speciﬁc ligands on neuronal pro-
cesses suggests that Notch signaling is  required at distal synapses.
3.  Regulation of Notch availability
Numerous reports have indicated critical checkpoints for Notch
expression and signaling. In this section we  will discuss some of
the most recent ﬁndings in Notch expression and processing regu-
lation.
3.1. Translational and post-translational regulation
It has recently been shown that in  Drosophila embryogene-
sis, Notch signaling can be regulated at the level of ligand and
receptor translation (Shepherd et al., 2009, 2010). The differen-
tial mRNA processing ensures the spatio-temporal dosage of the
receptor and ligand, which is necessary for proper development.
At present, we do not know whether RNA processing is  differen-
tially regulated in mammals. Nevertheless, we have shown that
Notch is rapidly translated from pre-existing mRNA upon synaptic
stimulation (Alberi et al., 2011) (Fig.  2). Interestingly, unpublished
evidence from our group has indicated that Notch mRNA is local-
ized at dendritic synapses, suggesting a  requirement for readily
available Notch transcripts at plasticity sites.
Moreover, it has recently been reported that a  trans-Golgi pro-
tein, Botch, regulates S1 cleavage of Notch, which is critical for
maturation of the Notch1 receptor (Chi et al., 2012). During neu-
ronal development, Botch promotes neurogenesis by negatively
regulating Notch expression. It remains to be understood how
Botch function is regulated and whether Botch activity can inﬂu-
ence Notch expression in neurons (Fig. 2).
Furthermore, glycosylation of the Notch receptor, by O-
fucosylation and O-glycosylation of the EGF repeats, has been
shown to be essential for proper signaling in Drosophila and mam-
mals (Stanley, 2007). The O-fucosyltransferase, Pofut, mutant mice
are viable but display T cell deﬁciency as a  result of reduced Notch-
ligand interaction and signaling (Ge  and Stanley, 2008; Zhou et al.,
2008). Two other reports using a  zebraﬁsh and a  fucosylation loss of
function mouse model, show that neuronal development and neu-
ronal plasticity are affected, likely through impairment in  Notch
signaling (Song et al., 2010; Yagi et al., 2012).
Taken together, several mechanisms regulate Notch protein
maturation thus granting proper signaling. It will be of interest to
determine whether any of these mechanisms are  affected during
aging or following injury.
3.2.  Ligand mediated regulation
There  have been extensive investigations demonstrating the
requirement for a membrane-tethered ligand to induce Notch acti-
vation in the signaling cell (Hicks et al., 2002; Lindsell et al.,
1995; Nichols et al., 2007). It  has been demonstrated that the
E3 ubiquitin ligases, neuralized and mindbomb, promote Notch
signaling by favoring the internalization of the ligand with the
Notch ectodomain in the ligand-presenting cell (Le Borgne et al.,
2005). Speciﬁcally, loss of Mindbomb-1 impairs Notch signaling
and affects neuronal development and radial glia formation (Koo
et al., 2007; Yoon et al., 2008). Thus, transactivation of the Notch
receptor by the ligand, restricts the polarity of the Notch signal (del
Alamo and Schweisguth, 2009).
Several reports using Drosophila have shown that when the lig-
ands, Delta or Serrate, and the Notch receptor are proximal at the
membrane of the same cell, in  “cis” conﬁguration, they exert a
ligand-mediated blockade on Notch activation through their intra-
cellular domain (de Celis and Bray, 1997; Glittenberg et al., 2006;
Miller et al., 2009) (Fig. 2). More recently it has been shown that
also  Notch, through its extracellular portion, can exert a  block on
Serrate mediate Notch activation (Becam et al., 2010). These ﬁnd-
ings indicate a mutual inhibitory interaction between ligand and
receptor when present at the membrane of the signaling cell. The
“cis” inhibition of ligand and receptor, in mammalian cells, has
been conﬁrmed using a  neuroblastoma cell line by overexpressing
Delta, which leads to  neurite extension. Conversely, when Delta is
expressed on ﬁbroblasts, it induces neurites shortening by transac-
tivating Notch (Franklin et al., 1999). In mammalian neurons, the
ligand Jagged1 is expressed in presynaptic terminals juxtaposed
to Notch, which is mainly expressed and induced postsynaptically
(Alberi et al., 2011). Interestingly, it appears that, in  Drosophila
sensory neurons, this conﬁguration is inverted: the Delta ligand is
expressed postsynaptically, whereas Notch is  present presynapti-
cally (Lieber et al., 2011). Therefore, also in the mature brain, spatial
separation of the ligand and receptor appears to grant signaling
directionality.
Furthermore, it has been shown that soluble ligands can com-
pete with the membrane-bound counterparts and repress signaling
(Hicks et al., 2002; Varnum-Finney et al., 2000). There are, however,
several reports showing that bath application of soluble ligands,
containing the DSL binding site  for Notch, can lead to Notch activa-
tion in neurons, neuronal stem cells and other mammalian cell lines
(Androutsellis-Theotokis et al., 2006; Kyriazis et al., 2010; Wang
et al., 2004). The presence of a  soluble ligand has been conﬁrmed in
a recent paper indicating constitutive ligand shedding by  ADAM-17
(Parr-Sturgess et al., 2010).
On  one side, it appears that a membrane anchored recep-
tor–ligand interaction is essential for signaling, while, on the other
hand, experimental evidence suggests the presence of a function-
ally active soluble ligand. This apparent discrepancy will need to
be further investigated. Nevertheless, it raises the possibility that
internalization of the Notch ectodomain with the ligand in the
signaling cell might not  be an absolute requirement for Notch acti-
vation, and that alternative mechanism of Notch activation may
take place. In the next chapter, we will discuss some of these puta-
tive mechanisms.
3.3.  Endocytic internalization of Notch
It remains a  topic of debate as to  whether Notch processing
occurs at the membrane or in  the endosomal compartment. A
recent study suggests that -secretase cleavage at the plasma mem-
brane generates a  more efﬁcient form of NICD (NICD-V), whereas
S3-cleavage in the endosome produces two short-lived NICD forms:
NICD-L and NICD-S (Tagami et al., 2008). This work also showed
that some FAD mutations of Presenilin1 affect the precision of
S3-cleavage, which may  contribute to diminished Notch signaling
(Tagami et al., 2008). It would be of interest to know if, in  neurons,
these labile forms are generated when NICD signal is  not required.
Interestingly, most of the NICD we observe in long-term neuronal
culture and cortical neurons, is  localized in  the cytoplasm, and very
little is present in the nucleus in  contrast to  maturing (Redmond
et al., 2000) or  injured neurons (Arumugam et al., 2011).
It  has previously been reported that endocytic processing
of Notch is associated with weaker signaling, due to ubiq-
uitination and degradation via Numb, which is a  conserved
intracellular modulator of Notch (Jafar-Nejad et al., 2002) (Fig.  2).
Interestingly, Numb associates with Cdc24, EphB2, NMDAR (N-
methyl-d-aspartate receptor) postsynaptically and contributes to
spine development (Nishimura et al., 2006). It would be interest-
ing to know whether Numb regulates the levels of Notch at the
synapse (Fig. 2).
Endosomal  trafﬁcking, however, appears instrumental for Notch
activation since systematic deletion of endocytic components, in
Drosophila, leads to accumulation and overactivation of Notch
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(Vaccari and Bilder, 2005; Vaccari et al., 2008). This study reveals
that endosomal trafﬁcking exerts a  necessary dampening effect on
Notch signaling. In addition, recent work has indicated that Notch
activation at the endosome, occurs independently of the ligand
(Childress et al., 2006; Hori et al., 2011). This might explain why, in
neurons, Notch processing is positively regulated by the endosomal
trafﬁcking molecule, Arc, regardless of ligand availability (Alberi
et al., 2011) (Fig. 2). Additionally, we have preliminary evidence
indicating that, upon synaptic stimulation, Notch is rapidly inter-
nalized into early endosomes and recycled to the surface (Fig.  2).
We are currently investigating whether the recycling of Notch is
directed from extrasynaptic to synaptic sites upon physiological
stimulation (Fig. 2).
Based  on the evidence that Notch is present at distal
postsynaptic sites and Presenilins activity is  maximal at the
endosome (Wu et al., 2011), we  argue that under physiolog-
ical conditions, endocytic trafﬁcking and processing might be
prevalent.
4. Notch signaling regulation
4.1.  Extrinsic modulatory inﬂuences on Notch signaling
There is growing evidence suggesting that Notch signaling is
susceptible to extrinsic factors. It has recently been reported that
ADAM activity can be induced by synaptic stimulation (Hoey
et al., 2009) and PKC activation (Cisse et al., 2011). Synaptic
stimulation can also induce -secretase activity at the endo-
some through the clustering of the complex Arc/Presenilin1 to
its substrates (Wu  et al., 2011). Interestingly, Notch activation, in
response to increased activity, occurs in mature neurons (Alberi
et al., 2011; Lieber et al., 2011) and in  neural stem cells of the
mature brain (Lugert et al., 2010). This suggests that activity
dependent Notch signaling may  be a  signature of mature Notch
function.
Notch and the amyloid precursor protein (APP) share com-
mon processing mechanisms through ADAM and -secretase, and
both substrates are processed in  an activity dependent manner
(Alberi et al., 2011; Hoey et al., 2009). Early reports suggest that
Notch1 and APP coprecipitate in  brain lysates and that they inter-
act through their transmembrane domain (Fassa et al., 2005; Kim
et al., 2007). It was also shown that the APP intracellular domain
(AICD), through interaction with Numb, can down-regulate Notch
signaling (Roncarati et al., 2002) (Fig. 2). It appears, therefore, that
APP and Notch have complementary functions. Nevertheless, it has
been recently proposed that the interaction between Numb and
Notch can be reverted upon stress conditions. This study showed
that trophic factor withdrawal induces a  switch in Numb isoform
to a shorter phosphotyrosine-binding domain (Numb-SPTB) that
favors endocytic sorting/processing of Notch (Kyriazis et al., 2010)
(Fig. 3). Therefore, in light of this study, we  may  hypothesize that
APP and Notch interaction through Numb is  either negative or pos-
itive depending on the cellular homeostasis. It  will be  interesting
to know whether aberrant synaptic activity as in  AD and epilepsy
(Palop and Mucke, 2009) can facilitate Notch signaling through
APP-Numb-SPTB induction.
One other study showed that, in  Drosophila blood cells, Sima, the
protein orthologous to the mammalian hypoxia-inducible factor-
alpha (Hif-1), is a strong activator of Notch independently of the
ligand (Mukherjee et al., 2011) (Fig. 3). It is  currently unknown
whether high levels of Hif-1 can activate Notch, in the mam-
malian brain, following cerebral ischemia (Chavez and LaManna,
2002).
Additional studies might help understand the underlying mech-
anism of Notch responses to  homeostatic changes.
4.2. Regulation within the nucleus
Notch transcriptional activity is  tightly regulated also at the level
of nucleus. The half-life of the transcriptionally active NICD-RBJK
complex is  determined by MAML-1. MAML-1 recruits cyclin depen-
dent kinase-8 (CDK8) to nuclear foci and allows phosphorylation of
NICD (NICD-P) and targeting of NICD-P for proteosomal degrada-
tion by E3 ubiquitin ligase Fbw7 (Fryer et al., 2004) (Figs. 2  and 3).
Recent work indicates that degradation of NICD by Fbw7 is essen-
tial for neural stem renewal and differentiation: genetic deletion of
Fbw7 leads to  NICD accumulation, progenitors’ apoptosis (Hoeck
et al., 2010) and neuronal–glial fate commitment (Matsumoto et al.,
2011). However, in  these studies it was not  shown whether accu-
mulation of NICD affects expression of Notch1 protein levels as
part of a  positive feedback loop. Notch1 self-regulation has been
reported in Drosophila (Del Monte et al., 2007) and murine embry-
onic neural stem cells (Li  et al., 2012).
RBPJK forms a constitutive repressor complex when associated
to Skip/SMRT/HDAC. A recent report using mammalian cell lines
has indicated that Wnt5a, through CamKII, can facilitate the export
of SMRT, enabling the interaction of Notch to  the RBPJK transcrip-
tional complex (Ann  et al., 2012). Interestingly, Wnt5a regulates
spine morphogenesis and synaptic plasticity (Varela-Nallar et al.,
2010). It is intriguing to hypothesize that this effect is achieved
through Notch function.
In  addition, the Drosophila ortholog of Hif-1, has a  stabiliz-
ing effect on the Notch-RBPJK transcriptional complex (Gustafsson
et al., 2005) (Fig. 3). It is  possible that Hif-1, which is strongly
induced by ischemia (Chavez and LaManna, 2002), can potentiate
Notch signaling in injury.
These and other yet undiscovered mechanisms might explain
the signaling power of Notch in  physiological and pathological con-
ditions.
5. Notch crosstalking to  other signaling pathways
Several studies have shown that the membrane-tethered form
of the Notch receptor and the activated NICD display signaling
capacity through the interaction with other signaling pathways
(Andersen et al., 2012; Le Gall et al., 2008; Sanalkumar et al., 2010).
In the next sections we will highlight signiﬁcant crosstalks with
putative neuronal function. We  believe that studies in this ﬁeld are
the foundation to understand the pleiotropic role of Notch in the
mammalian brain.
5.1.  Cytoplasmic crosstalk
The  work of Giniger on Notch/Abl (Abelson tyrosine-protein
kinase) signaling in  axon patterning, in  Drosophila, has pioneered
this research avenue. In various papers, the work from this group
has demonstrated that cytoplasmic Notch, lacking the transcrip-
tional active site, can effectively repress Abl signaling, by binding
to Disabled and Trio, thereby controlling axonal growth/guidance
(Crowner et al., 2003; Giniger, 1998) (Fig.  2). This suggests that at
distal sites from the nucleus Notch cooperates with local signaling
mechanism to display morphogenic functions.
Interestingly in  mammals, Disabled is  found downstream of
Reelin receptors and it is  instrumental for Reelin signaling (Herz
and Chen, 2006). It has, also, been shown that Reelin stabilizes
Notch signaling through the interaction with Disabled1 in devel-
oping neurons (Hashimoto-Torii et al., 2008) (Fig.  2). In addition,
dendritic maturation in Reeler (Reelin deﬁcient) mice can be  res-
cued by NICD expression (Hashimoto-Torii et al., 2008). Another
study revealed that Reelin deﬁciency leads to a strong reduc-
tion in  Notch activation and canonical signaling in the developing
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Fig. 3. Working model of Notch1 signaling in pathological conditions. Following injury, as in hypoxia–ischemia, Notch1 is rapidly processed through S2 and S3 clevage
and induces pathway activation. Notch1 levels are also increased probably in response to a positive Notch-CSL feedback. It is  possible that Botch, which blocks S1 cleavage
inﬂuencing Notch1 expression, is  directly involved in this process. NICD is  stabilized by the interaction with Hif-1. A stress-dependent Numb isoform (Numb-SPTB) favors
NICD-CSL activity. Notch1, through still unresolved mechanisms, positively interacts with NF-kappaB/JNK pathway to  mediate mitochondrial translocation of cytosolic
enzymes inducing apoptosis. NICD might be preferentially trafﬁcked to  the nuclei by  importin /, which are rapidly induced following injury. NICD, once in the  nucleus,
induces activation of downstream targets of the Hes, Herp gene families and other context dependent genes as cyclinD1 and p21. Hes1 may  downregulate ubiquitin ligases
MDM2  and IDE. Down-regulation of MDM2  stabilizes and thereby increases p53 levels which triggers the apoptotic cascade. p53, senses DNA damage, cooperates with Notch
also  in neurites retraction through Rho-GTPases (Rock1/2). Hes1 activation leads to down-regulation of IDE. This de-represses activation of BACE, through increase in AICD,
and  leads to transition from non-amylogenic to amylogenic A production. The gray separation indicates the long-range distance between a dendritic synapse and the cell
soma/nucleus.
hippocampus (Sibbe et al., 2009). This raises the possibility that
some of the traits observed in the various Reelin mutant mouse
models, such as decreased synaptic plasticity and spatial learning
(Beffert et al., 2005; Weeber et al., 2002) may  underlie impaired
Notch signaling.
Additional evidence that Notch might be instrumental in  neu-
ronal function through non-canonical neuronal modulator comes
from the work indicating that Notch interacts with the mam-
malian target of rapamycin (mTOR)-Akt pathway. This pathway is
essential in memory formation (Bekinschtein et al., 2007) and con-
solidation (Hoeffer et al., 2008). An interesting parallel between
Notch and mTOR function can be found in the common LTD
deﬁciency observed in  hippocampal slices treated with PI3K-Akt-
mTOR inhibitors (Hou and Klann, 2004) and the Notch1cKOs (Alberi
et al., 2011). A  mechanistic interaction has been shown in  HeLa and
embryonic stem cells. In the ﬁrst study, trophic factors removal can
induce Akt phosphorylation, through the interaction of NICD with
mTOR and the independent companion of mTOR (Rictor), indepen-
dently of Notch/RBPJK signaling (Perumalsamy et al., 2009) (Fig.  2).
On the other hand, it has been reported that application of  solu-
ble Notch ligands can induce phosphorylation of Akt and mTOR
in stem cells, which can be blocked by inhibiting Notch processing
(Androutsellis-Theotokis et al., 2006). It  is  intriguing to  hypothesize
that such a  positive interaction might take place also in  neurons.
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At this point, it is  mandatory to understand whether dysfunction
in the mTOR-Akt pathway occurs in  Notch1cKO neurons.
Other relevant work, that puts Notch in  connection with another
pathway involved in synaptic plasticity, indicates that Notch nega-
tively regulates Wnt  signaling by favoring degradation of -catenin.
This negative interaction seems to be facilitated by  Numb (Kwon
et al., 2011). Interestingly, both Notch and Wnt  cascade com-
ponents are expressed postsynaptically, are triggered by NMDA
transmission and inﬂuence synaptic plasticity (Alberi et al., 2011;
Ataman et al., 2008; Nishimura et al., 2006). A behavioral study
has shown that during memory consolidation, levels of Notch were
reduced, whereas -catenin expression was increased (Conboy
et al., 2007). It will be of interest to  understand whether these
components characterize speciﬁc memory traces.
Another remarkable interaction is  the crosstalk between Notch
and NF-B signaling. NF-B denotes a  dimeric transcriptional com-
plex composed by p55:p65. Interestingly, this dimer is  found at
synapses and can respond to  increase in local Ca2+ transients
(Meffert et al., 2003). It has been shown that these pathways have
synergistic functions in  physiological conditions and in  brain injury.
The Notch antisense mice (Notch1as), in which Notch is  partially
deleted (50–70%) using an antisense interference strategy (Cheng
et al., 2001), display speciﬁc synaptic plasticity defects coupled with
reduction in NF-B binding activity (Wang et al., 2004), suggest-
ing that Notch regulates NF-B signaling. Interestingly, p65 mutant
mice display defects in learning/memory processing (Meffert et al.,
2003) similar to the Notch1+/− and Notch1cKO mice (Alberi et al.,
2011; Costa et al., 2003). This positive interaction has been inves-
tigated more extensively in a hypoxia–ischemia injury paradigm.
Arumugam and colleagues have shown that Notch activation in an
ischemia-like injury model is  coupled with activation of the NF-B
pathway and can be blocked by application of several -secretase
inhibitors both in vitro and in vivo (Arumugam et al., 2006, 2011)
(Fig. 3). The latest study from this group indicated that nuclear
NICD is essential for NF-B/JNK activity, although the molecular
mechanism remains yet unraveled.
It appears, however, that NF-B activity can also regulate Notch
signaling. Reports revealed that Jagged1 is a  direct target of NF-
B (Bash et al., 1999) and that NF-B inﬂuences Notch signaling
by favoring the translocation of the nuclear corepressor of RBPJK
(Espinosa et al., 2002). Therefore Notch and NF-B pathway appear
to synergize in a positive feedforward and feedback mechanism.
Nevertheless, a recent investigation from Bonini has challenged
this hypothesis and has shown that, in hippocampal cultures from
p50 mutant mice, Jagged1 is overexpressed and triggers increased
Notch signaling. In addition, the authors claim that, as a result of
Notch activation, less dendritic branching is observed (Bonini et al.,
2011). This is somewhat surprising considering that Notch pro-
motes dendritic branching (Breunig et al., 2007; Redmond et al.,
2000). It remains possible that the effect of Notch on dendritic
morphology is partially mediated by NF-B signaling. Another pos-
sibility is that overactivation of Notch results in neurites retraction
and cell death. This latter point is of further interest because, if the
authors did not observe any sign of cell death, it would emphasize
that these pathways function together in  mediating neuronal cell
demise.
Studies looking at cytoplasmic interactions between Notch and
other signaling components will advance our understanding of
Notch signaling in the mature brain dramatically.
5.2. Nuclear crosstalk
We,  and others, have observed that under physiological condi-
tion, Hes1 and Hes5 expression (as readout of Notch-CSL signaling)
appear unresponsive to  changes in  Notch activity (Alberi et al.,
2011; Yu et al., 2001), whereas under ischemic condition there is
a strong up-regulation of Notch/RBPJK targets (Alberi et al., 2010;
Arumugam et al., 2006). We  may  speculate that, following injury,
Notch undergoes rapid Importin-mediated trafﬁcking and nuclear
signaling is favored (Huenniger et al., 2010) (Fig. 3). After axonal
injury, Importins-/ are rapidly translated in situ and function as
proteins’ carrier from the periphery to the nucleus, mediating either
pro survival or death signals (Hanz et al., 2003). This would be  in  line
with another work indicating that another Notch target, cyclinD1,
is induced following stroke (Timsit et al., 1999) (Fig.  3). Interest-
ingly, cyclinD1 heterozygous mice display partial neuroprotection
following kainic acid injury (Koeller et al., 2008), suggesting
that Notch signaling might be instrumental in  the life/death
choice.
In addition, Notch and APP proteins are aberrantly regulated in
Alzheimer’s disease (Woo  et al., 2009). Notch and APP appear to
have a mutual positive feedback on downstream targets (Fischer
et al., 2005). This would suggest that APP and Notch cooperate at
the level of transcription. Indeed, it has been shown that AICD and
NICD are found in nuclear factories in association with the effector
protein Fe65 (Konietzko et al., 2010). Another more recent study
indicates that Notch transcriptional activity, through Hes1, regu-
lates APP metabolism leading to de-repression of BACE-1 and an
increase in the production of A42 insoluble peptides that concen-
trates in amyloid plaques (Leal et al., 2012) (Fig. 3). This report is
very intriguing and indicates for the ﬁrst time a  direct regulation of
APP processing by Notch and a potential critical interaction in  the
pathobiology of Alzheimer’s disease.
There is additional evidence emerging from work in neurode-
velopment and differentiation that Notch cooperates with another
cell death signal, Trp53 (p53). Mice conditionally expressing NICD
under the Nestin promoter, displayed increased apoptosis of neu-
ronal progenitors during development. Apoptosis was  coupled with
aberrant increase in  p53 pathway activity and was  rescued by
genetic ablation of p53 (Yang et al., 2004). The positive feedback
of Notch on p53 has also been observed in mouse ﬁbroblasts. One
study indicated that Notch activation, through Notch/RBPJK activ-
ity, de-represses p53 expression by inhibiting the ubiquitin ligase,
MDM2,  which degrades p53 (Huang et al., 2004) (Fig.  3). Another
investigation using mouse ﬁbroblasts, lacking the ubiquitin ligase
Fbw7, showed that Notch activation is linked to p53 upregulation in
mediating cell cycle arrest (Ishikawa et al., 2008). A  mutual positive
feedback of p53 on Notch activity has also been recently reported:
p53, by sensing DNA damage, activates an apoptosis cascade in
neuronal stem cells and contributes, together with Notch, to reduc-
ing neurites’ length through the action of the small GTPase RhoA
kinases, Rock1 and Rock2 (Ferron et al., 2009) (Fig.  3). Similar results
have been obtained in keratinocytes (Lefort et al., 2007). From these
studies it appears that p53 and Notch functions are closely corre-
lated in life/death decision and neurites’ morphogenesis.
On the whole, it appears that Notch signaling is intertwined with
multiple conserved pathways also at the nuclear level. Future stud-
ies will help address how these different crosstalks are ﬁne-tuned
to mediate adaptive changes in neurons.
6. Notch in good times
6.1.  Notch in synaptic plasticity
When looking at the temporal expression pattern of Notch in
the cortex, it is  interesting to  observe that, around birth, Notch1
expression is  attenuated as compared to development. However,
after the ﬁrst postnatal week, expression becomes more abundant
(Tokunaga et al., 2004). This time coincides with the critical period
when synaptic connections are being reﬁned and spontaneous
synchronized activity patterns synaptic connections (Garaschuk
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et al., 2000). We might therefore hypothesize that during post-
natal development, Notch is  induced and required for network
maturation. Several papers have conﬁrmed this hypothesis and
have shown that Notch has a  direct effect on dendritic pattern-
ing (Berezovska et al., 1999; Breunig et al., 2007; Redmond et al.,
2000; Sestan et al., 1999) and axonal outgrowth (Crowner et al.,
2003). We  now know, from several studies, that reduction in  Notch
signaling affects sensory and memory processing across several
species (Alberi et al., 2011; Chao et al., 2005; Costa et al., 2003;
Ge et al., 2004; Wang et al., 2004). This effect does not  appear to  be
the result of aberrant connectivity, but rather depends on changes
in synaptic plasticity (Alberi et al., 2011). Interestingly, the plastic-
ity deﬁcit in the Notch1cKO does not completely phenocopy the
loss of Presenilin1/2 (PS1/PS2; PsdcKO) (Saura et al., 2004). In  the
PsdcKO mice, the LTP deﬁcit is  accompanied by  reduced presynap-
tic release, which can neither be observed in the Notch1cKOs nor in
Notch1as mice. This suggests that Presenilin1/2 may  also regulate
essential functions of presynaptic substrates that inﬂuence neu-
rotransmitter release. The postsynaptic function of Notch is also
supported by the fact that bath application of Jagged1 potentiates
LTP (Wang et al., 2004).
Interestingly,  a  more recent report indicates that conditional
deletion of Mindbomb-1, which is instrumental for ligand endo-
cytosis and Notch signaling (Koo et al., 2005), leads to a synaptic
plasticity and memory deﬁcit (Yoon et al., 2012). This provides
additional evidence that, in the mature brain, Jagged1 might be
instrumental for Notch-dependent plasticity. Interestingly, Alag-
ille patients, carrying genetic mutation for Jagged1, besides the
liver and heart pathology, also display signs of mental retardation
(Alagille et al., 1975). It  would be  of interest to know whether this
is the result of impaired connectivity or plasticity in  the brain.
Canonical  Notch signaling has been shown to be  critical for
spatial learning and memory, based on the evidence that RBPJK
heterozygous mice display a  similar deﬁcit as the Notch heterozy-
gous mice (Costa et al., 2003). Nevertheless, a recent paper has
shown that postnatal deletion of RBPJK does not affect memory and
learning (Sato et al., 2012). This study concludes that Notch/RBPJK
signaling is dispensable for synaptic plasticity. In addition, NICD
overexpression in pyramidal neurons of the visual cortex reduces
spine density and represses long-term potentiation (Dahlhaus et al.,
2008). This suggests that ectopic NICD interferes with physiologi-
cal Notch functions and/or that non-transcriptional Notch activity
is instrumental in neuronal physiology. In this direction, a  study in
Drosophila has indicated that the adhesion molecule, Klingon, is a
direct non-canonical/non-transcriptional target of Notch in a  mem-
ory paradigm, and that it is instrumental for long term memory
formation (Matsuno et al., 2009). This study is very intriguing and
suggests that non-canonical mediators of Notch may  be  involved
in synaptic plasticity and memory processing.
On the whole, it appears that transient increase of Notch in
response to activity is essential in  synaptic plasticity modulation
(Alberi et al., 2011; de Bivort et al., 2009; Lieber et al., 2011). Never-
theless it has been shown that Notch signaling is  attenuated during
the period of memory consolidation (Conboy et al., 2007). This
raises the interesting possibility that Notch signaling is  respon-
sible for early rather than late molecular changes at the synapse
following potentiation.
Ultimately, these studies highlight that Notch signaling is  an
essential requirement for neuronal function and memory forma-
tion.
6.2. Notch in postnatal neurogenesis
In the mature brain, Notch signaling is  additionally implicated
in adult neurogenesis of the subventricular zone (SVZ) (Basak et al.,
2012; Imayoshi et al., 2010; Nyfeler et al., 2005) and subgranular
zone  of the hippocampus (SGZ) (Lugert et al., 2010). Neurogenesis,
and integration of new born neurons is  thought to contribute to
olfaction (SVZ) (Sakamoto et al., 2011) and spatial memory (SGZ)
(Kempermann and Gage, 2002).
Canonical Notch/RBPJK signaling is  essential in maintaining a
neurogenic pool in  the mature brain (Basak et al., 2012; Imayoshi
et al., 2010; Lugert et al., 2010). It  has been shown that abla-
tion of RBPJK in  adult neural stem cells (NSCs) of the SVZ induces
a transient increase in  neurogenesis but leads in the long term
to a  permanent depletion of the progenitor pool (Imayoshi and
Kageyama, 2011). Another recent study, using conditional dele-
tion mouse models for Notch1 and RBPJK in adult NSC of the SVZ,
has conﬁrmed that loss of functional Notch signaling exhausts the
progenitor pool (Basak et al., 2012). This same study indicates a
functional separation between Notch1 and RBPJK function and indi-
cates that Notch1 does not regulate the cell fate of quiescent NSCs,
which, instead, appears to  be under RBPJK regulation, probably
through the other heterologous receptors, Notch2 and Notch3. The
group of Taylor has also demonstrated, at least in  two  papers, that
Notch1 is  important in maintaining an actively proliferating NSCs
pool, which selectively lost during aging (Basak et al., 2012; Lugert
et al., 2010).
Work from the same group has indicated that, similar to  the
SVZ, ablation of RBPJK in  NSCs of the postnatal DG  leads to  a
strong depletion in progenitor cells (Lugert et al., 2010). Using a
Notch reporter line, in  which cells with ongoing Notch/RBPJK are
GFP labeled (Hes5::GFP), the authors found that NSCs of  SGZ  with
Notch/RBPJK signaling are the most multipotent of the total progen-
itors. In basal conditions these NSCs are, for the large part quiescent,
but can rapidly switch into a  neurogenic mode in  response to max-
imal activity or exercise (Lugert et al., 2010, 2012). This important
study indicates that the regenerative potential of neuronal progen-
itors is responsive to increased synchronized activity. As  a  matter
of fact, neurogenesis in  the SGZ can be induced by exercise (van
Praag et al., 1999), environmental enrichment (Brown et al., 2003)
and synaptic potentiation (Kameda et al., 2012). Other extrinsic
sensory factors, as olfaction, can increase neurogenesis in the SVZ
(Rochefort et al., 2002). We may  hypothesize that this process is
mediated by activity-dependent Notch activation, although other
signaling pathways, such as PI3K/AKT (Bruel-Jungerman et al.,
2009), BDNF/TrkB (Bergami et al., 2009) and Wnt  signaling (Lie
et al., 2005) have also been implicated in these processes.
Beside  the role in neural stem maintenance, Notch also regulates
integration of newborn neurons in  the granule cell layer (Breunig
et al., 2007). Various studies using animal models have shown
that, during aging (Ben Abdallah et al., 2010; Lugert et al., 2010)
and Alzheimer’s disease, neurogenesis is  considerably reduced
(Jaskelioff et al., 2011; Rodriguez et al., 2008, 2009). In  addition,
several loss of function of Presenilins display reduced neurogene-
sis (Chen et al., 2008b; Chevallier et al., 2005; Faure et al., 2011).
Despite the multiple targets of -secretase, we  believe that, in light
of the recent ﬁndings, perturbation in Notch may  contribute to  the
deﬁcit in neurogenesis observed in  these studies.
Therefore Notch signaling appears instrumental for the regen-
erative capacity of the mature brain.
7. Notch in bad times
7.1.  Notch in Alzheimer’s disease
Notch signaling has often been implicated in AD, however, at
present, the mechanisms involving Notch in progressive neurode-
generation remains elusive. Several familial AD (FAD) mutations
of Presenilin1, leading to early onset dementia, are associated
with diminished Notch activity (Chavez-Gutierrez et al., 2012;
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Moehlmann et al., 2002; Steiner et al., 2001). In addition, FAD
mutations of presenilin produce longer and more lipophilic N
peptides in analogy to the amylogenic A42 at the expense of
the non-amylogenic A40 forms (Okochi et al., 2002). A42 are
responsible for insoluble amyloid plaque formation. The efﬁciency
of -secretase appears to be affected during aging. In fact, in  the
brains of aged mice, -secretase activity increased APP process-
ing and A42 production, whereas Notch1 processing is reduced
(Placanica et al., 2009).
In  contrast to the previous reports indicating a  reduction in
Notch activity in AD, two other studies showed a  signiﬁcant
increase in Notch expression/activity in  sporadic Alzheimer’s dis-
ease (Berezovska et al., 1998; Nagarsheth et al., 2006). In addition,
other neurodegenerative diseases such as Down syndrome (Fischer
et al., 2005), Pick’s (Nagarsheth et al., 2006) and Prion’s disease
(Ishikura et al., 2005), are characterized by  concomitant increases
in Notch expression and amyloid plaques formation. It  remains to
be understood why progressive neurodegenerative diseases have
different mechanisms in  terms of Notch processing and signaling,
and whether Notch effectively contributes to their pathobiology.
Beside  the unresolved role of Notch in AD, the common pro-
cessing mechanism of Notch and APP has posed serious challenges
in the development of drugs that can counteract the progres-
sion of AD: Pre-clinical trials using -secretase inhibitors have
reduced amyloid plaques deposition but have often caused intesti-
nal bleeding and immunosuppression due to the inhibition of Notch
signaling (Wong et al., 2004). Therefore, in recent years, more com-
pounds have been developed that target APP metabolism without
affecting Notch signaling (Wolfe, 2012). These novel drugs might
improve not only the peripheral actions of the compounds, but also
spare Notch signaling in the brain.
Further studies aimed at unraveling the molecular mediators
of Notch-dependent processes in progressive neurodegenerative
disease will further contribute to the development of better preven-
tive and therapeutic strategies to counteract imbalances in Notch
signaling in aging and AD.
7.2. Notch in ischemic injury
Several  studies have shown that, following ischemic injury,
Notch signaling is aberrantly up-regulated (Alberi et al., 2010;
Arumugam et al., 2006; Lou et al., 2012; Shimada et al., 2011).
Notch induction following injury results in  a  plethora of effects and
can contribute to damage as well as regeneration. In  mature neu-
rons, Notch1 (Arumugam et al., 2006) and Notch2 (Arumugam et al.,
2011; Ferrari Toninelli et al., 2003) are both induced, suggesting a
summation of downstream effects.
The involvement of Notch in  ischemia-induced cell death has
been further shown by  the work of Arumugam et al. (2011), where
Notch appears to interact with the NF-B components p65, p50 and
Bim in the apoptotic process in vitro and in vivo (Fig.  3). The only
caveat of this latter study is the chemical in vivo loss of function
model utilized (-secretase inhibitors [GSI]). These drugs inhibit
the processing of several -secretase substrates at the same time
(Selkoe and Wolfe, 2007) and it is  therefore difﬁcult to study speciﬁc
implications of Notch signaling in any of these processes. Employ-
ing genetic loss of function along with GSI is strongly recommended
to understand the clinical relevance of this pathway.
Another recent study, using both GSI and a  Notch loss-of-
function model, has shown that Notch signaling is crucial for
inducing NF-B driven microglia responses, similar to  what occurs
in mature neurons (Wei  et al., 2011). The microglial response
upon injury is notorious for producing an immuno-inﬂammatory
response that can worsen and amplify neuronal damage (Stoll et al.,
1998). Similarly, another recent study indicates that Notch1 is
directly  involved in reactive gliogenesis, contributing to  the cell
invasion in  the peri-infarct area (Shimada et al., 2011).
Following cerebral ischemia, angiogenesis and vessel sprouting
takes place. Notch1 is  an important angiogenic factor both dur-
ing development (Limbourg et al., 2005) and postnatally (Takeshita
et al., 2007). It appears that, following cerebral ischemia, Notch
plays an important role in reperfusion and the reorganization of
the microcirculation (Lou et al., 2012). Besides Notch1, Notch3
plays a  fundamental role in  the vasculature, where it is  speciﬁcally
expressed in smooth muscle cells of the endothelium. Mutations in
the Notch3 genes induce CADASIL, which is  characterized by pro-
gressive brain ischemia and vascular dementia (Dichgans, 2007).
Notch3 mutant mice have conﬁrmed the fundamental require-
ment of Noch3 in vasculature reorganization following ischemic
challenge (Arboleda-Velasquez et al., 2008). More recently, two
transgenic mouse lines carrying distinct CADASIL mutations show
hypomorphic Notch3 activity and with age develop smooth muscle
cells abnormalities similar to human CADASIL (Arboleda-Velasquez
et al., 2011). Therefore, it appears that inhibiting Notch signaling
early after injury can provide some beneﬁcial effects by limit-
ing the increased inﬂammatory response, provided by reperfusion
(Arumugam et al., 2006). On the other hand, it might be  expected
that long-term blockade of Notch can worsen the scenario by  pre-
venting regeneration (Hofmann and Iruela-Arispe, 2007).
In  addition, Notch activation has been shown to  be essential in
neural stem cell proliferation in several hypoxia–ischemia rodent
models (Androutsellis-Theotokis et al., 2006; Carlen et al., 2009;
Chen et al., 2008a; Oya et al., 2009; Wang et al., 2009). Canonical
Notch signaling is activated through a  hypoxia-dependent mech-
anism (Johnson, 2011; Seidel et al., 2010), as well as through
overexpression of the ligand (Androutsellis-Theotokis et al., 2006;
Liu et al., 2011). Neural stem cells of the SGZ and SVZ, which are
quiescent under physiological conditions, have been shown to  pro-
liferate following injury (Kawai et al., 2005; Lugert et al., 2010),
probably in  an attempt to repair brain damage. Notch signaling,
which is  a  known neurogenic factor (Gaiano and Fishell, 2002),
has been shown to be central in  this process, as demonstrated by
genetic and chemical loss of function models (Kawai et al., 2005;
Oya et al., 2009; Wang et al., 2009; Xin et al., 2006). Interestingly,
this regenerative potential, in response to  injury, is  diminished with
aging (Lugert et al., 2010).
Some  time after stroke, attenuation of Notch signaling appears
to be required for integration of newly born neurons in  the
hippocampal network (Oya et al., 2009). On  the other hand,
a recent report has shown that 1 week after kainate injury,
Notch-dependent stem cell proliferation is short-lived and cell
fate commitment, mainly of astroglial type, occurs (Sibbe et al.,
2012). This discrepancy might be explained by distinct micro-
environmental reactions in  hypoxia–ischemia and ischemia where
Notch–DSL interactions with either Jagged1 or Deltalike1 lead
to neurogenic (Nyfeler et al., 2005) or gliogenic commitment
(Grandbarbe et al., 2003), respectively. Application of exogenous
Jagged1 might promote the neurogenic potential in the sclerotic
scar and provide a beneﬁcial inﬂuence in  terms of regeneration
and neuronal replenishment.
Interestingly, it has recently been proposed that canonical Notch
signaling is  induced by isoﬂuorane preconditioning and can medi-
ate neuroprotective functions following focal ischemia (Yang  et al.,
2012). It has been proposed that preconditioning, using sub-lethal
insults, can activate signaling cascades such as NF-B and HIF that
have neuroprotective functions (Gidday, 2006). It  is  possible that
Notch activation, through a yet unknown mechanism, takes part
in these pro-survival processes. Interestingly, a recently identiﬁed
neuroprotective gene, Botch (Dai et al., 2010), can regulate Notch
expression (Chi et al., 2012). Similar dual functions have also been
described for another pathway: PIK3/AKT (Brown, 2007; Sawe et al.,
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2008), which has been intimately connected to  Notch in  the sur-
vival/death choice in cancer (Calzavara et al., 2008; Chan et al.,
2007; Gutierrez and Look, 2007; Palomero et al., 2007).
On  the whole, it appears that several Notch-dependent pro-
cesses are triggered by cerebral hypoxia–ischemia. Understanding
the molecular dynamics of this signaling cascade will help devise
more effective therapeutic approaches that inﬂuence this pathway
and can limit brain damage and favor regeneration.
8. Conclusions
In this review, we  have focused on the role of Notch signaling
in the mature brain. We have attempted to give an overview col-
lecting signiﬁcant ﬁndings from past and present investigations.
It emerges that Notch is critical for physiological brain functions
from neurogenesis to memory processing. In addition, aberrant
activation following brain injury appears to  contribute on one side
to neuronal demise, triggering apoptotic processes and increasing
inﬂammatory responses, and on the other side to regeneration. The
molecular mechanisms beyond such diverse functions are currently
a subject of intense study and we expect it to increase in  the future.
For the yet unsolved mechanisms, we  have looked at other biologi-
cal models such as development and cancer, where Notch has been
extensively studied. In this way, we have tried to ﬁll the current bio-
logical gap in order to ﬁnd possible explanations for Notch function
in the mature brain. We  have also reported brain diseases, such as
AD and stroke, where Notch signaling alterations are reported. We
have also mentioned some of the challenges in drug development
that target -secretase dysfunctions due to off-target effects on the
Notch pathway. We  believe that this cascade, at the pace of other
highly conserved pathways, plays a crucial role in  brain physiology
and pathology. We expect that in the next decade, several break-
through discoveries will be made, connecting the dots in the brain
“signalome”. These works will help the development of new thera-
peutic strategies for the prevention and treatment of brain disease
in which Notch is directly implicated.
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